TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: hazard rates <259 days of gestation
Endpoint domain: Mortality/survival
Primary endpoint: hazard rates <273 days of gestation
Endpoint domain: Mortality/survival
Primary endpoint: mean gestation durations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Duration of indwelling catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urinary incontinence
Endpoint domain: Adverse events/effects
Primary endpoint: IPSS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Borg scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean plasma iPTH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of ear discomfort and blockage during diving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teed scores after diving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean improvement in NEI VFQ‐25 total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean change in CRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI z-scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in metabolic syndrome prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident HIV infections
Endpoint domain: Mortality/survival
Primary endpoint: Pregnancy during the trial
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: TCM symptoms and signs improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAG rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: relief of pain on walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: night pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical function subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chronic thoracic pain incidence
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: media deconstruction skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of HIV infection
Endpoint domain: Mortality/survival
Primary endpoint: Rates of nausea, vomiting, or elevated alanine aminotransferase levels
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of drug discontinuation due to hepatic or renal abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: between-laboratory SD of GI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total effectiveness against seasonal influenza virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Indirect effectiveness against seasonal A/H3N2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total effectiveness against pandemic influenza virus (A/H1N1pdm09)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of upper extremity motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to completion in shoulder arthroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Injury grading index in shoulder arthroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to completion in knee arthroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cognitive task accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from TLF at 1-year
Endpoint domain: Mortality/survival
Primary endpoint: Clinically driven target lesion revascularization (TLR) at 1-year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frequency of air leak from stapler holes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: percentage of slough at day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete healing of the anal fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total AOFAS Ankle‐Hindfoot score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Need for ongoing opioid analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: increased skin firmness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Motile sperm concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: client perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful extubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate associated with failed extubation
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Daily nursing workload for manual repositioning
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Inducibility of clinical arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Inducibility of nonclinical arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Noninducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived gastrointestinal discomfort-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: feasibility and acceptability of psychological intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Short-serve accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-serve accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SFDs per 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target effect-site concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: singleton live birth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of ovarian hyperstimulation syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Specificity of Gd-BOPTA-enhanced MR angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of nonassessable below-the-knee segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: epithelialization in the tonsil bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regular oral intake time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal obstruction evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of total PVD at the time of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for vitrectomy surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Stroke Volume Index (SVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stroke Work Index (SWI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical response to prophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at outpatient treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peak ALT >3 × ULN
Endpoint domain: Adverse events/effects
Primary endpoint: 1,5-AG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: risk of hypoglycemia and hyperglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery of vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average ECD at 3, 6, and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral ECD change from baseline to 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: epithelial change time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stricture of external auditory canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cleaning function of external auditory canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD severity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mortality HR associated with conversion to permanent access
Endpoint domain: Mortality/survival
Primary endpoint: Pharyngeal Airway Space (PAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF erectile domain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality rate from acute pancreatitis
Endpoint domain: Mortality/survival
Primary endpoint: mortality rate in patients with moderate to severe pancreatitis
Endpoint domain: Mortality/survival
Primary endpoint: Time to metabolic normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Significant cutaneous, respiratory or cardiovascular reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Testosterone level normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Basic follicle number decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Development of LCOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain response to heel prick
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical failure requiring second surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of skin erosions
Endpoint domain: Adverse events/effects
Primary endpoint: Single-dose pharmacokinetics of ponatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total femur BMD change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone turnover change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of response to treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: drinking quantity and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative AKI of KDIGO grade 2 or 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Menstrual blood loss reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microTBS (microtensile bond strength)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral embolism with neurological deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mortality due to embolic events
Endpoint domain: Mortality/survival
Primary endpoint: Silent embolism as documented on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Difficulty with laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of serious ventricular arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: triacylglycerol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: predicted vertebral strength characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average volumetric density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strength:density ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Culture negativity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: misuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in clinical parameters (PI, GI, PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gain in RAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Stable mean blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Boston index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distal sensory latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: focal lesion sFF as an imaging biomarker of treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHF-related death or hospital stay for CHF
Endpoint domain: Mortality/survival
Primary endpoint: RA graft patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinical and scintigraphic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: later blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean epithelial defect size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative mean spherical equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interference of pain on physical and emotional functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal uptake of monoclonal antibody fragments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease in mean serum liver enzymes (AST, ALT, ALP, GGT) and bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: surgical and healing complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: vertical bone gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neck-related disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPIS (Clinical Pulmonary Infection Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VAP (Ventilator-Associated Pneumonia) development
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of incident ischemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean reduction in treatment area circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean reduction in skin fat thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of the immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: measures of physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of compliance therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: time to recurrence of a mood event (mania or depression)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBF response to acetazolamide stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach TOF 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of second primary cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: cTnT concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Premenstrual mood symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patient-reported antihypertensive medication use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mitral e'/a' ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular global peak systolic strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Glutathione level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Addiction severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular regional wall motion abnormality (RWMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recreation of native footprint surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: pain intensity while going up and down stairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of femoral BMLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: tibial cartilage defects score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PICU lengths of stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: antibiotic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocyte transcriptome alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in visual analogue scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Japanese Orthopedic Association Score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Disability Index score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of scleral defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delay in wound epithelialisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual functioning improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total mean costs
Endpoint domain: Resource use
Primary endpoint: Complete resolution of clinical syndrome within 10 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean recovery time in hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Smell acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Texture acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall analgesic effect (TOPAR8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: full remission (HDRS < or = 10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of major depression
Endpoint domain: Adverse events/effects
Primary endpoint: T-cell-related IFN-γ mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Asthma quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MPC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurological examination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cognitive processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: recall of face-name associations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: performance on specific functional tasks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ulcer recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking cessation rates at 4 weeks postquit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum IGFBP‐3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of thromboembolic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes